Bharat Parenterals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹99.62 crore, reflecting a quarter-on-quarter *(QoQ) increase of 52.81 per cent from ₹65.19 crore. This corresponds to a year-on-year *(YoY) decline of 4.19 per cent.
Operating Profit
Operating Profit stands at ₹-0.53 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 130.46 per cent from ₹1.74 crore. This corresponds to a year-on-year *(YoY) decline of 123.77 per cent.
PBDT
PBDT stands at ₹0.26 crore, reflecting a quarter-on-quarter *(QoQ) increase of 44.44 per cent from ₹0.18 crore. This corresponds to a year-on-year *(YoY) growth of 23.81 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-8.37 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.09 per cent from ₹-8.28 crore. This corresponds to a year-on-year *(YoY) decline of 0.72 per cent.
Net Profit
Net Profit stands at ₹-8.16 crore, reflecting a quarter-on-quarter *(QoQ) increase of 15.62 per cent from ₹-9.67 crore. This represents a 13.56 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Bharat Parenterals Ltd Earnings
- YOY
- QOQ
Bharat Parenterals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Bharat Parenterals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Bharat Parenterals Ltd Financial Reports
Bharat Parenterals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Bharat Parenter. | 2.90% | 9.27% | 12.76% | 23.59% | 26.60% | 21.29% |
| Ind-Swift Labs. | -2.33% | -0.19% | -2.01% | -10.33% | 40.15% | 74.47% |
| Bajaj Healthcare | 0.31% | 11.02% | -8.33% | -10.86% | -28.72% | -49.32% |
| Wanbury | 0.92% | 13.02% | 9.72% | 12.33% | 22.52% | -0.70% |
| Themis Medicare | 1.34% | 3.75% | 3.21% | 21.36% | -1.82% | -28.28% |
| Fermenta Biotec. | -0.18% | 4.96% | -3.69% | -11.01% | 10.21% | 0.88% |
| Shree Ganesh Rem | 2.02% | 12.17% | 19.52% | 20.11% | 35.15% | 2.28% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Bharat Kumar R Desai
Executive Director : Hemang Jayendrabhai Shah
Independent Non Exe. Director : Shaileshkumar Ghabhawala
Independent Non Exe. Director : Zankhana Sheth
Independent Non Exe. Director : Mukesh Patel
Non-Exec & Non-Independent Dir : Alkesh Jayantilal Shah
Company Sec. & Compli. Officer : Sharmin Nareshkumar Soni